… of inhaled corticosteroid and long-acting β-agonist (IC/LABA) … In addition, a post-bronchodilator
spirometry was performed … ) association with the predicted variable in a univariate …

… The recommended first choices in pharmacologic therapy for stable COPD according to
each category are as follows: short-acting bronchodilators are recommended for patients in …

… Overall forest plot meta-analysis of the impact of long-acting muscarinic antagonist/long-acting
β2-agonist combinations on trough FEV 1 and subgroup analysis performed on lower and …

… section on pharmacological treatment of stable COPD in the new … treatment will consist of
long-acting bronchodilators (LABD). … population were patients with FEV 1 <50% predicted, who …

… PS were derived from predicted probabilities of treatment … factors, proxies of COPD severity,
concomitant respiratory … management of stable chronic obstructive pulmonary disease: …

… ; a predicted post-bronchodilator forced expiratory volume in 1 s (FEV 1 ) of ≤ 70%; a FEV
1 /forced vital capacity ratio of < 0.70 at first visit; and a score of ≥ 2 on the modified Medical …

… to predict morbidity and mortality of individual patients based on … While management of
stable COPD became more … for long-term treatment, long-acting bronchodilators are preferred. …

… long-acting bronchodilators for high-risk symptomatic COPD … In fact, in subgroups of stable
COPD patients with high … trial where COPD patients (mean FEV 1 50% predicted) were …

… that blood eosinophil counts predict the magnitude of the … or LAMA-LABA combination in
patients with stable COPD disease. … treatment in combination with long-acting bronchodilators in …

… many patients who are receiving long-acting bronchodilators … LABA/LAMA FDCs in the
treatment of stable COPD were more … the New Zealand PREDICT Cardiovascular Disease Cohort …